Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of the intestinal microbiota and microbial metabolites in acute GVHD
Dandan Lin, Bo Hu, Pengfei Li, et al.
Experimental Hematology and Oncology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 828
Lipocalin-2 expression identifies an intestinal regulatory neutrophil population during acute graft-versus-host disease
Marie Czech, Sophia Schneider, Nina Peltokangas, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 735
Closed Access | Times Cited: 17
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
Ke Zhao, Ren Lin, Zhiping Fan, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 46
Gut microbiota, microbiota‐derived metabolites, and graft‐versus‐host disease
Xiaoyan Yue, Hongyu Zhou, Shufen Wang, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 12
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract
Zachariah DeFilipp, Ashish Damania, Haesook T. Kim, et al.
Blood Advances (2024) Vol. 8, Iss. 9, pp. 2074-2084
Open Access | Times Cited: 8
Association between oral and fecal microbiome dysbiosis and treatment complications in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
Maura Faraci, Carola Bonaretti, Gianluca Dell’Orso, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Ocular graft‐versus‐host disease: Risk factors of ocular graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation in Denmark
Helene Jeppesen
Acta Ophthalmologica (2025) Vol. 103, Iss. S286, pp. 3-19
Open Access
Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease
Xiaoying Qiao, Jarosław Biliński, Leyi Wang, et al.
Bone Marrow Transplantation (2022) Vol. 58, Iss. 1, pp. 10-19
Open Access | Times Cited: 21
Gut Microbiota Disruption in Hematologic Cancer Therapy: Molecular Insights and Implications for Treatment Efficacy
Patricia Guevara‐Ramírez, Santiago Cadena-Ullauri, Elius Paz‐Cruz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10255-10255
Open Access | Times Cited: 4
The Gut Virome and Human Health: From Diversity to Personalized Medicine
Rahul Harikumar Lathakumari, K.V. Leela, Anusha Gopinathan, et al.
Engineering Microbiology (2025), pp. 100191-100191
Open Access
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
Kevin McDonnell
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2040-2040
Open Access
Rhino-orbito-cerebral mucormycosis after allogeneic hematopoietic stem cell transplantation for very severe aplastic anemia in a child: a case report
Yimei Ma, Ziting Xia, Bochao Cheng, et al.
Frontiers in Pediatrics (2025) Vol. 13
Open Access
Clostridium butyricum MIYAIRI 588 contributes to the maintenance of intestinal microbiota diversity early after haematopoietic cell transplantation
Kentaro Fukushima, Hayami Kudo, Kentaro Oka, et al.
Bone Marrow Transplantation (2024) Vol. 59, Iss. 6, pp. 795-802
Open Access | Times Cited: 3
Human Amniotic Mesenchymal Stem Cells Alleviate aGVHD after allo-HSCT by Regulating Interactions between Gut Microbiota and Intestinal Immunity
Xiaoyin Bu, Junhui Wang, Zhao Yin, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 5, pp. 1370-1383
Open Access | Times Cited: 8
Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic Approach
Salomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2256-2256
Open Access | Times Cited: 2
Human β-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling
Tamina Rückert, Geoffroy Andrieux, Melanie Boerries, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 676
Open Access | Times Cited: 10
Human umbilical cord mesenchymal stem cells ameliorate acute graft-versus-host disease by elevating phytosphingosine
Tao Hong, Rui Wang, Guancui Yang, et al.
Experimental Hematology (2023) Vol. 122, pp. 19-29
Closed Access | Times Cited: 5
Klebsiella quasipneumoniae in intestine damages bile acid metabolism in hematopoietic stem cell transplantation patients with bloodstream infection
Guankun Yin, Yifan Guo, Qi Ding, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 4
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Valentin Wenger, Robert Zeiser
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 3, pp. 101567-101567
Open Access | Times Cited: 1
The role of fecal microbiota transplantation in the treatment of acute graft-versus-host disease
Zhi Guo, Mingxin He, Liang Shao, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 7, pp. 1964-1973
Open Access | Times Cited: 1
A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD
Jiahua Li, Xueyan Zhang, Yiru Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 7
Safe use of fecal microbiota transplant in treatment of graft versus host disease in a 5-year-old child
Anna Fałkowska, Adam Jakubas, Laura Surdacka, et al.
Acta Haematologica Polonica (2023) Vol. 54, Iss. 4, pp. 266-268
Open Access | Times Cited: 3
Clostridioides difficile Infection in Patients after Organ Transplantation—A Narrative Overview
Sylwia Dudzicz, Andrzej Więcek, Marcin Adamczak
Journal of Clinical Medicine (2022) Vol. 11, Iss. 15, pp. 4365-4365
Open Access | Times Cited: 5
The Promise of Precision Nutrition for Modulation of the Gut Microbiota as a Novel Therapeutic Approach to Acute Graft-versus-host Disease
Arun Prasath Lakshmanan, Sara Deola, Annalisa Terranegra
Transplantation (2023) Vol. 107, Iss. 12, pp. 2497-2509
Open Access | Times Cited: 2
High Diversity but Monodominance of Multidrug-Resistant Bacteria in Immunocompromised Pediatric Patients with Acute Lymphoblastic Leukemia Developing GVHD Are Not Associated with Changes in Gut Mycobiome
Sára Šardzíková, Kristina Andrijkova, Peter Švec, et al.
Antibiotics (2023) Vol. 12, Iss. 12, pp. 1667-1667
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top